Agios Pharmaceuticals, Inc. (AGIO)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 06, 2025

$33.54

P/E Ratio

2.95

Market Cap

$1.91B

Loading...
Description

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Metrics

Overview

  • HQCambridge, MA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerAGIO
  • Price$33.54+4.19%

Trading Information

  • Market cap$1.91B
  • Float96.68%
  • Average Daily Volume (1m)1,306,599
  • Average Daily Volume (3m)821,730
  • EPS$11.79

Company

  • Revenue$32.87M
  • Rev growth (1yr)21.15%
  • Net income$947.92M
  • Gross margin76.26%
  • EBITDA margin-1,131.93%
  • EBITDA-$101.47M
  • EV$1.65B
  • EV/Revenue50.26
  • P/E2.95
  • P/S59.62
  • P/B1.18
Documents